May 14, 2024 - There's a quiet revolution happening in law firm business development across the globe — code named Activator. From the Magic Circle to the Am Law 200 and beyond — law firms are ...
Agios Pharmaceuticals faces major competitive and regulatory headwinds in sickle cell disease and thalassemia, leading to a rating downgrade to a cautious 'Hold.' Novo Nordisk's PK activator looks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results